2seventy bio Inc (NASDAQ:TSVT) shares, rose in value, with the stock price down by -1.80% to the previous day’s close as strong demand from buyers drove the stock to $4.92.
Actively observing the price movement in the last trading, the stock closed the session at $5.01. The value of beta (5-year monthly) was 1.85. Referring to stock’s 52-week performance, its high was $12.69, and the low was $1.53. On the whole, TSVT has fluctuated by -13.23% over the past month.
With the market capitalization of 2seventy bio Inc currently standing at about $252.45 million, investors are eagerly awaiting this quarter’s results, scheduled for May 01, 2024 – May 06, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.75, which is expected to increase to -$0.16 for fiscal year -$2.17 and then to about -$0.65 by fiscal year 2025. Data indicates that the EPS growth is expected to be 50.90% in 2025, while the next year’s EPS growth is forecast to be 70.00%.
Analysts have estimated the company’s revenue for the quarter at $15.28 million, with a low estimate of $11.81 million and a high estimate of $22.1 million. According to the average forecast, sales growth in current quarter could jump down -31.50%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $82.77 million, representing a decrease of -17.50% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that TSVT’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of TSVT currently trading nearly 2.46% and -2.78% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.95, while the 7-day volatility ratio is showing 11.80% which for the 30-day chart, stands at 12.81%. Furthermore, 2seventy bio Inc (TSVT)’s beta value is 1.85, and its average true range (ATR) is 0.57.
A comparison of 2seventy bio Inc (TSVT) with its peers suggests the former has fared considerably weaker in the market. TSVT showed an intraday change of -1.80% in last session, and over the past year, it shrunk by -50.90%%.
Data on historical trading for 2seventy bio Inc (NASDAQ:TSVT) indicates that the trading volumes over the past 10 days have averaged 1.16 million and over the past 3 months, they’ve averaged 1.40 million. According to company’s latest data on outstanding shares, there are 50.63 million shares outstanding.
Nearly 6.84% of 2seventy bio Inc’s shares belong to company insiders and institutional investors own 95.15% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.25 million shares as on Mar 15, 2024, resulting in a short ratio of 5.49. According to the data, the short interest in 2seventy bio Inc (TSVT) stood at 10.23% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 5.81 million. The stock has risen by 15.22% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TSVT stock heading into the next quarter.
